These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 604117)

  • 1. In vitro markers for measuring residual virulence for men of live attenuated influenza viruses.
    Boudreault A; Diaz-Rodriguez P; Lecomte J
    Dev Biol Stand; 1977 Jun 1-3; 39():33-40. PubMed ID: 604117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An 'in vitro' marker of attenuation for live influenza virus vaccine candidates.
    Mostow SR; Flatauer S; Martinko J
    Dev Biol Stand; 1975; 28():354-62. PubMed ID: 1126579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of man and animals against influenza by oral and intranasal routes.
    Boudreault A; Boulay G; Marois P; Pavilanis V
    Dev Biol Stand; 1976; 33():171-7. PubMed ID: 782965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of ciliary activity in organ cultures of ferret trachea in reference to genetic and biological characters in influenza virus strains.
    Diaz-Rodriguez P; Boudreault A
    Can J Microbiol; 1982 Jul; 28(7):809-14. PubMed ID: 6756625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity, immunogenicity and genetic stability in mice and ferrets of a cold inhibitor-resistant mutant of influenza H3N2 virus.
    Závadová H; Stárek M; Dolezalová B; Vonka V
    Dev Biol Stand; 1976; 33():151-4. PubMed ID: 955266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live influenza vaccine: screening of attenuated virus strains by a 50% ciliary activity inhibition test in organ cultures of ferret trachea.
    Boudreault A
    Can J Microbiol; 1979 Mar; 25(3):279-84. PubMed ID: 378337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge.
    Delem A
    Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interfering activity of virulent and attenuated influenza virus strains.
    Dekhtyareva NI; Medvedeva TE; Aleksandrova GI
    Acta Virol; 1976 Jun; 20(3):189-95. PubMed ID: 9798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory and clinical characteristics of attenuated strains of influenza virus.
    Maassab HF; Francis T; Davenport FM; Hennessy AV; Minuse E; Anderson G
    Bull World Health Organ; 1969; 41(3):589-94. PubMed ID: 5309481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines.
    Ghendon YZ
    Bull World Health Organ; 1984; 62(3):493-9. PubMed ID: 6331910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of influenza virus mutants for possible use in a live virus vaccine.
    Mills J; Van Kirk J; Hill DA; Chanock RM
    Bull World Health Organ; 1969; 41(3):599-606. PubMed ID: 5309483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of species and organ-specific features of tissue systems on the reactogenic and immunogenic properties of influenza virus.
    Gorev NE
    Acta Virol; 1975 Jan; 19(1):41-6. PubMed ID: 235196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
    Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
    J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.
    Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI
    Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity to pyrexial temperatures: a factor contributing to virulence differences between two clones of influenza virus.
    Sweet C; Cavanagh D; Collie MH; Smith H
    Br J Exp Pathol; 1978 Aug; 59(4):373-80. PubMed ID: 708585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies with live attenuated influenza vaccines.
    Douglas RG; Betts RF
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):153-8. PubMed ID: 685888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.